These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21394525)

  • 1. Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk.
    Salman S; Sy SK; Ilett KF; Page-Sharp M; Paech MJ
    Eur J Clin Pharmacol; 2011 Sep; 67(9):899-908. PubMed ID: 21394525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk.
    Ilett KF; Paech MJ; Page-Sharp M; Sy SK; Kristensen JH; Goy R; Chua S; Christmas T; Scott KL
    Br J Clin Pharmacol; 2008 May; 65(5):661-6. PubMed ID: 18294329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic analysis of tramadol and
    Lee J; Yoo HD; Bae JW; Lee S; Shin KH
    Drug Des Devel Ther; 2019; 13():1751-1761. PubMed ID: 31213765
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
    Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
    Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
    Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
    Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomeric determination of tramadol and O-desmethyltramadol by liquid chromatography- mass spectrometry and application to postoperative patients receiving tramadol.
    Musshoff F; Madea B; Stuber F; Stamer UM
    J Anal Toxicol; 2006 Sep; 30(7):463-7. PubMed ID: 16959140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study.
    Allegaert K; Holford N; Anderson BJ; Holford S; Stuber F; Rochette A; Trocóniz IF; Beier H; de Hoon JN; Pedersen RS; Stamer U
    Clin Pharmacokinet; 2015 Feb; 54(2):167-78. PubMed ID: 25258277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.
    Long T; Cristofoletti R; Cicali B; Michaud V; Dow P; Turgeon J; Schmidt S
    J Clin Pharmacol; 2022 Jan; 62(1):76-86. PubMed ID: 34383318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a high-performance liquid chromatography method for tramadol and o-desmethyltramadol in human plasma using solid-phase extraction.
    Gan SH; Ismail R
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(2):325-35. PubMed ID: 11499486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats.
    Pypendop BH; Ilkiw JE
    J Vet Pharmacol Ther; 2008 Feb; 31(1):52-9. PubMed ID: 18177319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol and metabolites O-desmethyltramadol and N-desmethyltramadol in adult horses.
    Stewart AJ; Boothe DM; Cruz-Espindola C; Mitchum EJ; Springfield J
    Am J Vet Res; 2011 Jul; 72(7):967-74. PubMed ID: 21728858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
    Stamer UM; Musshoff F; Stüber F; Brockmöller J; Steffens M; Tzvetkov MV
    Pain; 2016 Nov; 157(11):2467-2475. PubMed ID: 27541716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic modelling of tramadol using inverse Gaussian function for the assessment of drug absorption from prolonged and immediate release formulations.
    Brvar N; Mateović-Rojnik T; Grabnar I
    Int J Pharm; 2014 Oct; 473(1-2):170-8. PubMed ID: 25014367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Consequences of Tramadol in Overdosing: Dilemma of a Polymorphic Cytochrome P450 2D6-Mediated Substrate.
    Srinivas NR
    J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):272-5. PubMed ID: 26367475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenstrual age and CYP2D6 polymorphisms determine tramadol o-demethylation in critically ill neonates and infants.
    Allegaert K; van Schaik RH; Vermeersch S; Verbesselt R; Cossey V; Vanhole C; van Fessem M; de Hoon J; van den Anker JN
    Pediatr Res; 2008 Jun; 63(6):674-9. PubMed ID: 18317231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
    Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
    Borlak J; Hermann R; Erb K; Thum T
    Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the pharmacokinetics of tramadol: on the difference between CYP2D6 extensive and poor metabolizers.
    Di Patti F; Fanelli D; Pedersen RS; Giuliani C; Torricelli F
    J Theor Biol; 2008 Oct; 254(3):568-74. PubMed ID: 18640130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.